BerandaPHS • FRA
add
Photocure ASA
Tutup sebelumnya
€4,43
Rentang hari
€4,51 - €4,51
Rentang tahun
€3,97 - €5,75
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (NOK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 141,68Â jt | -0,61% |
Biaya operasional | 133,01Â jt | 16,48% |
Laba bersih | -4,32Â jt | -132,74% |
Margin laba bersih | -3,05 | -132,97% |
Penghasilan per saham | -0,21 | -145,65% |
EBITDA | 5,74Â jt | -78,73% |
Tarif pajak efektif | 467,72% | — |
Neraca
Total aset
Total liabilitas
| (NOK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 288,83Â jt | 12,68% |
Total aset | 739,09Â jt | 3,81% |
Total liabilitas | 237,37Â jt | 3,60% |
Total ekuitas | 501,72 jt | — |
Saham yang beredar | 27,11 jt | — |
Harga terhadap nilai buku | 0,24 | — |
Tingkat pengembalian aset | 0,41% | — |
Tingkat pengembalian modal | 0,57% | — |
Arus Kas
Perubahan kas bersih
| (NOK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -4,32Â jt | -132,74% |
Kas dari operasi | 15,42Â jt | -21,49% |
Kas dari investasi | -1,64Â jt | -232,50% |
Kas dari pembiayaan | -10,98Â jt | 33,17% |
Perubahan kas bersih | 2,80Â jt | -37,01% |
Arus kas bebas | -4,74Â jt | 2,79% |
Tentang
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
Didirikan
1993
Situs
Karyawan
100
